We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory... Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States. Show more
Ask ADVFN Intelligence (AI)
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the...
Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE...
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than...
RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of...
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.88 | 6.58682634731 | 13.36 | 14.6 | 13.205 | 1639439 | 13.6865294 | CS |
| 4 | 3.57 | 33.458294283 | 10.67 | 14.6 | 10.46 | 1258533 | 12.44821422 | CS |
| 12 | 2.9747 | 26.4058658003 | 11.2653 | 14.6 | 9.41 | 1235563 | 11.38569129 | CS |
| 26 | -1.61 | -10.1577287066 | 15.85 | 16.18 | 9.41 | 1227302 | 11.41572686 | CS |
| 52 | -2.19 | -13.3292757152 | 16.43 | 19.8702 | 9.41 | 897585 | 13.02239909 | CS |
| 156 | -10.82 | -43.1763766959 | 25.06 | 28.62 | 9.41 | 852773 | 16.71278479 | CS |
| 260 | -20.77 | -59.3259068837 | 35.01 | 45.48 | 9.41 | 832353 | 20.50890353 | CS |
| Symbol | Price | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 731.1M |
| NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.5M |
| RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 341.8M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 237.15M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
